What is Pharmazz?
Pharmazz, Inc., established in 2010 and headquartered in Willowbrook, Illinois, is a biopharmaceutical firm dedicated to the development of novel treatments for critical care and neurological conditions. The company has a robust global footprint, notably through its subsidiary Pharmazz India Pvt Ltd, indicating a strategic focus on international markets. Its operational scope spans the development and potential commercialization of advanced therapies, positioning it as a key player in the competitive biopharmaceutical landscape.
How much funding has Pharmazz raised?
Pharmazz has raised a total of $40M across 2 funding rounds:
Private Equity
$15M
Private Equity
$25M
Private Equity (2024): $15M with participation from Sun Pharma
Private Equity (2025): $25M led by Sun Pharma
Key Investors in Pharmazz
Sun Pharma
Sun Pharma is a specialty generic pharmaceutical company headquartered in Mumbai, India, focused on manufacturing and distributing pharmaceutical formulations and active pharmaceutical ingredients.
What's next for Pharmazz?
With the recent major strategic investment, Pharmazz is poised for accelerated development and potential market penetration of its therapeutic candidates. The substantial enterprise-level funding suggests a trajectory towards scaling operations, expanding research and development capabilities, and potentially pursuing further clinical trials or regulatory approvals. This capital infusion is expected to fuel the company's mission to address unmet medical needs in critical care and neurology, reinforcing its commitment to innovation and global health.
See full Pharmazz company page
